Sun Min Lim
2025
Figure S3 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
2025 • Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo, Chai Young Lee, Seul Lee, Joon Yeon Hwang, Youngtaek Kim, Seong-san Kang, Sujeong Baek, Kwang...
2025
Supplementary Data 1 Legend from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
2025 • Sun Min Lim, Seong-san Kang, Dong Kwon Kim, Soo‐Hwan Lee, Chun‐Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin...
2025
Supplementary Figure 3 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
2025 • Sun Min Lim, Seong-san Kang, Dong Kwon Kim, Soo‐Hwan Lee, Chun‐Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin...
2025
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study
2025 • Kevin J. Harrington, Ari J. Rosenberg, Muh Hwa Yang, J.L. Geiger, Marc Oliva, Sun Min Lim, Will Ince, Aarti Bhatia, Robert Metcalf, Kiichiro Toyoiz...
2025
Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study
2025 • Mariam Alexander, Ying Cheng, Se-Hoon Lee, Antonio Passaro, Alexander I. Spira, Byoung Chul Cho, Sun Min Lim, Yuichiro Ohe, Adnan Nagrial, Jiunn Li...
Open Author Page
Exploring foci of
2025-07-15
Subcutaneous versus intravenous amivantamab, both in combination with lazertinib, in refractory EGFR-mutated non-small cell lung cancer: Patient satisfaction and resource utilization results from the PALOMA-3 study
2025-07-15 • Mariam Alexander, Ying Cheng, Se-Hoon Lee, Antonio Passaro, Alexander I. Spira, Byoung Chul Cho, Sun Min Lim, Yuichiro Ohe, Adnan Nagrial, Jiunn Li...
In PALOMA-3, subcutaneous amivantamab, which simplifies and shortens administration, reduces resource utilization, and enhances treatment experience, was a preferred option for patients who received amivantamab-lazertinib.
Open Article Page
Deep Blue Versus Garry Kasparov
Subcutaneous Emphysema
Alcatraz Versus The Evil Librarians
Joe Versus The Volcano
Lola Versus Powerman And The Moneygoround, Part One
Gratis Versus Libre
Aliens Versus Predator 2
Intravenous Therapy
Subcutaneous Administration
Open Article Page
Exploring foci of
2025-03-04
Figure S3 from Denfivontinib Activates Effector T Cells Through the NLRP3 Inflammasome, Yielding Potent Anticancer Effects by Combination with Pembrolizumab
2025-03-04 • Dong Kwon Kim, Chun‐Bong Synn, Wongeun Lee, Ha-Ni Jo, Chai Young Lee, Seul Lee, Joon Yeon Hwang, Youngtaek Kim, Seong-san Kang, Sujeong Baek, Kwang...
<p>T cell subset gating strategy for flow cytometry analysis. The definition of each subset is shown in the figure.</p>
Open Article Page
Hello Muddah, Hello Fadduh (A Letter From Camp)
So Far From God
Tales From Planet Earth
Plan 9 From Outer Space
Javier Fernández (Figure Skater)
Away From Her
The Girl From Everywhere
The View From Saturday
Suicide Notes From Beautiful Girls
Open Article Page
Exploring foci of
2025-03-28
Supplementary Data 1 Legend from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
2025-03-28 • Sun Min Lim, Seong-san Kang, Dong Kwon Kim, Soo‐Hwan Lee, Chun‐Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin...
<p>Data legend for supplementary data 1, showing the process chart and raw whole slide images of multiplex IHC.</p>
Open Article Page
Computer Data Storage
Tokenization (Data Security)
Honda Legend
The Legend Of Korra (Season 2)
Data Fusion
The Legend Of Haolan
The Legend Of Tarzan (Tv Series)
Brütal Legend
The Legend Of Maula Jatt
Open Article Page
Exploring foci of
2025-03-28
Supplementary Figure 3 from Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma
2025-03-28 • Sun Min Lim, Seong-san Kang, Dong Kwon Kim, Soo‐Hwan Lee, Chun‐Bong Synn, Sujeong Baek, Seung M. Yang, Yu J. Han, Mi H. Kim, Heekyung Han, Kwangmin...
<p>Figure S3 shows the gating strategy for M panel in immune profiling analysis.</p>
Open Article Page
Hello Muddah, Hello Fadduh (A Letter From Camp)
So Far From God
Tales From Planet Earth
Plan 9 From Outer Space
Javier Fernández (Figure Skater)
Away From Her
The Girl From Everywhere
The View From Saturday
Suicide Notes From Beautiful Girls
Open Article Page
Exploring foci of
2025-11-22
Subcutaneous amivantamab in recurrent/metastatic head and neck squamous cell cancer after disease progression on checkpoint inhibitor and chemotherapy: Preliminary results from the phase 1b/2 OrigAMI-4 study
2025-11-22 • Kevin J. Harrington, Ari J. Rosenberg, Muh Hwa Yang, J.L. Geiger, Marc Oliva, Sun Min Lim, Will Ince, Aarti Bhatia, Robert Metcalf, Kiichiro Toyoiz...
Overexpression of EGFR and MET occurs in a high proportion of recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC). Amivantamab, an EGFR-MET bispecific antibody with immune-cell directing activity, is approved in EGFR-mutated advanced non-small cell lung cancer and is being evaluated in phase 3 trials for other solid tumors. Cohort 1 of OrigAMI-4 (NCT06385080) enrolled adult participants with human papillomavirus-unrelated R/M HNSCC with disease progression on/after prior checkpoint inhi…
Open Article Page
Subcutaneous Tissue
Recurrent Neural Network
Subcutaneous Administration
Subcutaneous Emphysema
Bidirectional Recurrent Neural Networks
Gated Recurrent Unit
Chronic Recurrent Multifocal Osteomyelitis
Recurrent Laryngeal Nerve
Open Article Page